INmune Bio Inc. (INMB) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Inmune Bio Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.923 Greetings and welcome to the InMuneBio first quarter 2025 earnings call. 00:00:04.923 -- 00:00:07.931 At this time, all participants are in a listen-only mode. 00:00:07.931 -- 00:00:11.259 Later, you will have the opportunity to ask questions during the question and answer 00:00:11.259 -- 00:00:16.367 session. You may register to ask a question at any time. 00:06:09.391 -- 00:06:12.495 by pressing star 1 on your telephone keypad. 00:06:12.495 -- 00:06:15.038 You may withdraw yourself from the queue by pressing star 2. 00:06:15.038 -- 00:06:18.683 As a reminder, this conference is being recorded. 00:06:18.683 -- 00:06:23.109 A transcript will follow within 24 hours of this conference call. 00:06:23.109 -- 00:06:26.132 At this time, it is my pleasure to introduce 00:06:26.132 -- 00:06:30.057 Mr. David Moss, CFO of ImmuneBio. David? 00:06:30.057 -- 00:06:32.781 Thank you, Jessie, and good afternoon, everyone. 00:06:32.781 -- 00:06:37.847 We thank you for joining us for the call for ImmuneBio's first quarter 2025 financial 00:06:37.847 -- 00:06:40.883 results. With me on the call today are Dr. 00:06:40.883 -- 00:06:46.131 RJ Tesse, CEO of Immune Bio, and Dr. Mark Liddell, Chief Scientific Officer 00:06:46.131 -- 00:06:50.758 of Immune Bio, who will provide an update on our cords for many immune programs. 00:06:50.758 -- 00:06:56.927 Also on the call is Dr. CJ Barnum, Head of Neuroscience, who will be here to answer questions. 00:06:56.927 -- 00:07:00.954 Before we begin, I remind everyone that except for statements of historical facts, the 00:07:00.954 -- 00:07:04.719 statements made by management and responses to questions on this conference call are 00:07:04.719 -- 00:07:09.240 forward-looking statements under the Safe Harbors provis...